Clinicare (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.25 M
as on 06-12-2024
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.31%
(FY 2023)
- Profit -7.88%
(FY 2023)
- Ebitda 81.00%
(FY 2023)
- Net Worth 13.31%
(FY 2023)
- Total Assets 17.22%
(FY 2023)
About Clinicare (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdeep Shah and Binish Shah serve as directors at the Company.
- CIN/LLPIN
U33110MH1988PTC045863
- Company No.
045863
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Clinicare (India) Private Limited offer?
Clinicare (India) Private Limited offers a wide range of products and services, including IT, Networking & Automation Solution, IT Solutions, Pen, Pencil & Writing Supplies, Pen Parts.
Who are the key members and board of directors at Clinicare (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdeep Shah  | Whole-Time Director | 13-Jan-1988 | Current |
| Binish Shah | Director | 01-Oct-1992 | Current |
Financial of Clinicare (India).
Clinicare (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.31% increase. The company also saw a slight decrease in profitability, with a 7.88% decrease in profit. The company's net worth Soared by an impressive increase of 13.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinicare (India)?
Unlock access to Clinicare (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nish Neeta Chemicals Private LimitedActive 36 years 9 monthsJagdeep Shah and Binish Shah are mutual person
- Sha Investco (India) Private LimitedActive 32 years 11 months
Jagdeep Shah and Binish Shah are mutual person
- Chemocid Impex Private LimitedActive 32 years 11 months
Jagdeep Shah and Binish Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinicare (India)?
Unlock and access historical data on people associated with Clinicare (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinicare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinicare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
